Maintenance notice: Some features that submit or update information are temporarily disabled while we migrate the website. You can continue browsing normally. Thank you for your understanding.
ST. PAUL, Minn.--(BUSINESS WIRE)--
St. Jude Medical, Inc. (STJ), a global medical device company, today reported sales and net earnings for the second quarter ended July 2, 2016.
Second quarter 2016 highlights:
Net sales of $1.562 billion increased 11 percent as reported, or 2 percent on a comparable constant currency basis.
International sales increased 10 percent as reported, or 7 percent on a comparable constant currency basis where a full portfolio of products is available.
Neuromodulation sales increased 19 percent as reported, or 20 percent on a constant currency basis driven by the most comprehensive product portfolio on the market.
Atrial fibrillation sales increased 13 percent as reported and on a constant currency basis driven by strong growth across the product portfolio.
If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!
Improving orthopaedic care, education and research using Internet technologies